Publications:

HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma.

Translational Lung Cancer Research

Jia, Ziqi Z; Xing, Jiahua J; Li, Ji J; Wang, Weiwei W; Wang, Yadong Y; Song, Yang Y; Yang, Xiaoying X; Xue, Jianchao J; Ye, Junyi J; Li, Bing B; Han-Zhang, Han H; Zhao, Jiaxing J; Zhang, Xiaochun X; Peng, Feng F; Chen, Fengxia F; Chen, Xueqin X; Lu, Yan Y; Ying, Shenpeng S; Wu, Dongping D; Zhang, Xinwei X; Ma, Caixia C; Lai, Lipeng L; Ma, Songling S; Liang, Dianjing D; Liu, Peng P; Li, Xiaoguang X; Liang, Naixin N; Li, Shanqing S

Publication Date: 2021-03

Variant appearance in text: BRAF: I659M

PubMed Link: 33889517

Variant Present in the following documents:

• Main text
• tlcr-10-03-1383.pdf

View BVdb publication page